Literature DB >> 2440523

Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions.

P Voorn, G Roest, H J Groenewegen.   

Abstract

Unilateral 6-hydroxydopamine lesions of the mesostriatal dopaminergic system in the rat resulted in a decrease of substance P-immunoreactivity in the ventral striatum, and in a heterogeneously distributed increase of enkephalin-immunoreactivity in the dorsal and ventral striatum and the globus pallidus. The respective decrease and increase are caused by a lower or higher staining intensity of the peptidergic fibers, whereas no changes were found in the cell bodies.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2440523     DOI： 10.1016/0006-8993(87)91149-8

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


  13 in total

1.  Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.

Authors:  Jordi Bové; Jordi Serrats; Guadalupe Mengod; Roser Cortés; Eduardo Tolosa; Concepció Marin
Journal:  Exp Brain Res       Date:  2005-06-21       Impact factor: 1.972

Review 2.  The role of dopamine-dependent negative feedback in the hippocampus-basal ganglia-thalamus-hippocampus loop in the extinction of responses.

Authors:  I G Sil'kis
Journal:  Neurosci Behav Physiol       Date:  2008-05

3.  Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway.

Authors:  C A Ingham; S H Hood; B van Maldegem; A Weenink; G W Arbuthnott
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

Review 4.  Dopamine and synaptic plasticity in the neostriatum.

Authors:  G W Arbuthnott; C A Ingham; J R Wickens
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

5.  Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys: implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology.

Authors:  J S Schneider; E Decamp; T Wade
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

6.  Alterations in striatal glial fibrillary acidic protein expression in response to 6-hydroxydopamine-induced denervation.

Authors:  J G Sheng; S Shirabe; N Nishiyama; J P Schwartz
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

7.  The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum.

Authors:  C Konradi; L A Kobierski; T V Nguyen; S Heckers; S E Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

8.  Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer.

Authors:  G D Phillips; T W Robbins; B J Everitt
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

9.  Dopamine and endogenous opioid regulation of picrotoxin-induced locomotion in the ventral pallidum after dopamine depletion in the nucleus accumbens.

Authors:  L Churchill; M C Austin; P W Kalivas
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion.

Authors:  R Granata; G K Wenning; J Jolkkonen; P Jenner; C D Marsden
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.